/
Nexalin is headquartered, and maintains its base of management and operations, in Houston, Texas. We design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.
The business is unprofitable at the operating level (-2781.69% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 78.8% YoY with margins expanding 1814.4pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$276K
▲ +78.8% YoY
Net Income (TTM)
-$8M
▼ -8.1% YoY
Op. Margin
-3084.22%
▲ +1814.4pp YoY
ROIC
-154.66%
▼ -0.7pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$5M
▼ -25.7% YoY
Net Debt
-$3M
Net Cash Position
Cash & Equiv.
$3M
3Y CAGR: -38.9%
Continue Research